🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Current clinical practices has shown promising prospects of the therapy str...
Status
Completed
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-12-04
Trial ID
NCT04846491
Patients with malignant melanoma who had undergone surgery will receive adj...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00723710
Treatments Being Tested
This pilot clinical trial studies recombinant interferon alfa-2b in treatin...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2008-04-22
Trial ID
NCT01460875
Treatments Being Tested
This is a dose-seeking and efficacy study of combined BRAF Inhibitor Vemura...
Status
Completed
Location
Hillman Cancer Center
Start Date
2013-10
Trial ID
NCT01943422
Treatments Being Tested
The purpose of this study is to compare the relapse free survival and overa...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2012-08
Trial ID
NCT01782508
Treatments Being Tested
This randomized phase III clinical trial studies combination chemotherapy w...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
1994-07
Trial ID
NCT00002556
The objective is to evaluate the efficacy and safety of the combination the...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00686777
Treatments Being Tested
RATIONALE: Interferon alfa may interfere with the growth of tumor cells and...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2003-12
Trial ID
NCT00082719
Treatments Being Tested
This was a Phase 2, open-label study of KW2871 (ecromeximab) in combination...
Status
Completed
Location
University of Chicago Hospital
Start Date
2008-03-28
Trial ID
NCT00679289
This is a Phase IIIB, randomized, prospective, multicenter, single-country,...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-18
Trial ID
NCT00237484